Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol versus intravenous ibuprofen for patent ductus arteriosus in very preterm infants
ACTRN12614000754640Phase 4Withdrawn
- Sponsor
- Monash Newborn
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in patent ductus arteriosus (PDA) comparing Oral paracetamol with Intravenous ibuprofen (2 arms). Primary endpoint: PDA closure or reduction in size by more than 50%. Planned start Aug 2014; status: withdrawn.
02
Drugs
acetaminophenibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on ACTRN12614000754640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000754640.